Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)
Clinical trial NCT03809429 · COMPLETED
Trial details
- NCT number
- NCT03809429
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-29
- Primary completion
- 2022-02-16
- Enrollment
- 437
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.